Abstract
The introduction of computed tomography (CT) and magnetic resonance (MR) imaging has resulted in the detection of increasing numbers of asymptomatic intraventricular tumors. Establishing the correct preoperative diagnosis is important to prevent unnecessary surgical intervention. Our study includes nine cases of benign lateral ventricle tumors including two cases of central neurocytoma, two of subependymal giant cell astrocytoma, two of pilocytic astrocytoma and three of subependymoma treated surgically between 1996 and 2003. MR imaging, proton MR spectroscopy (1H-MRS) and thallium-201 single photon emission computed tomography (201Tl-SPECT) were performed in all patients. All three types of tumor demonstrated heterogeneous enhancement on MR imaging with gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) and increased choline (Cho) peak and decreased N-acetyl aspartate (NAA) and creatine (Cre) peaks on 1H-MRS. 201Tl-SPECT showed high uptake of 201Tl without wash out in all cases of central neurocytoma, subependymal giant cell astrocytoma and pilocytic astrocytoma, but no uptake in cases of subependymoma. Absence of 201Tl uptake in contrast with enhancement on MR imaging and the 1H-MRS features of modest elevation of the Cho/Cre ratio, reduction of the NAA peak and presence of lactate/lipid peaks are characteristic features of subependymomas and useful to establish a preoperative diagnosis.
Similar content being viewed by others
References
Ancri D, Basset JY, Lonchampt MF, Etavard C (1978) Diagnosis of cerebral lesions by thallium 201. Radiology 128:417–422
Ancri D, Basset JY (1980) Diagnosis of cerebral metastases by thallium 201. Br J Radiol 53:443–453
Chiechi MV, Smirniotopoulos JG, Jones RV (1995) Intracranial subependymomas: CT and MR imaging features in 24 cases. Am J Roentgenol 165:1245–1250
Gill SS, Small RK, Thomas DG, Patel P, Porteous R, Van Bruggen N, Gadian DG, Kauppinen RA, Williams SR (1989) Brain metabolites as 1H-NMR markers of neuronal and glial disorders. NMR Biomed 2:196–200
Im SH, Paek SH, Choi YL, Chi JG, Kim DG, Jung HW, Cho BK (2003) Clinicopathological study of seven cases of symptomatic supratentorial subependymoma. J Neurooncol 61:57–67
Jayasundar R, Shah T, Vaishya S, Singh VP, Sarkar C (2003) In vivo and in vitro MR spectroscopic profile of central neurocytomas. J Magn Reson Imaging 17:256–260
Jelinek J, Smirniotopoulos JG, Parisi JE, Kanzer M (1990) Lateral ventricular neoplasms of the brain: differential diagnosis based on clinical, CT, and MR findings. Am J Roentgenol 155:365–372
Kanamori M, Kumabe T, Shimizu H, Yoshimoto T (2002) 201Tl-SPECT, 1H-MRS, and MIB-1 labeling index of central neurocytomas: three case reports. Acta Neurochir (Wien) 144:157–163
Kazner E, Wende S, Grumme TH (1982) Computed tomography in intracranial tumors. Springer, Berlin Heidelberg New York
Kendall B, Reider-Grosswasser I, Valentine A (1983) Diagnosis of masses presenting within the ventricle on computed tomography. Neuroradiology 25:11–22
Kim DG, Han MH, Lee SH, Chi JG, Cho KJ, Kim JH, Choi KS, Han DH (1993) MRI of intracranial subependymoma: report of a case. Neuroradiology 35:185–186
Kim DG, Choe WJ, Chang KH, Song IC, Han MH, Jung HW, Cho BK (2000) In vivo proton magnetic resonance spectroscopy of central neurocytoma. Neurosurgery 46:329–334
Kumabe T, Shimizu H, Sonoda Y, Shirane R (1999) Tallium-201 single photon emission computed tomographic and proton magnetic resonance spectroscopic characteristics of intracranial ganglioglioma: three case reports. Neurosurgery 45:183–187
Lee JD, Kim DI, Lee JT, Chan JW, Park CY (1995) Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI. J Nucl Med 36:537–541
Lobato RD, Sarabia M, Castro S, Esparza J, Cordobes F, Portillo JM, Rivas JJ (1986) Symptomatic subependymoma: report of four new cases studied with computed tomography and review of the literature. Neurosurgery 19:594–598
Lombardi D, Scheithauer BW, Meyer FB, Forbes GS, Shaw EG, Gibney DJ, Katzmann JA (1991) Symptomatic subependymoma: a clinicopathological and flow cytometric study. J Neurosurg 75:583–588
Maiuri F, Gangemi M, Iaconetta G, Signorelli F, Del Basso De Caro M (1997) Symptomatic subependymomas of the lateral ventricles. Report of eight cases. Clin Neurol Neurosurg 99:17–22
Morrison G, Sobel DF, Kelley WM, Norman D (1984) Intraventricular mass lesions. Radiology 153:435–442
Oguchi M, Higashi K, Taniguchi M, Nishikawa T, Tamamura H, Okimura T, Yamamoto I (1998) Single photon emission CT images in a case of intraventricular neurocytoma. Ann Nucl Med 12:161–164
Onizuka M, Suyama K, Shibayama A, Hiura T, Horie N, Miyazaki H (2001) Asymptomatic brain tumor detected at brain check-up. Neurol Med-Chir (Tokyo) 41:431–435
Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK (1995) Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. Am J Neuroradiol 16:1593–1603
Roeder MB, Jinkins JR, Bazan C (1994) Subependymoma of the filum terminale: MR appearance. J Comput Assist Tomogr 18:129–130
Shimizu H, Kumabe T, Tominaga T, Kayama T, Hara K, Ono Y, Sato K, Arai N, Fujiwara S, Yoshimoto T (1996) Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. Am J Neuroradiol 17:737–747
Shimizu H, Kumabe T, Hara K, Fujiwara S, Yoshimoto T (2000) Cho level measured by proton magnetic resonance spectroscopy correlate with Ki-67 labeling index in gliomas. Am J Neuroradiol 21:659–665
Silverstein JE, Lenchik L, Stanciu MG, Shimkin PM (1995) MRI on intracranial subependymomas. J Comput Assist Tomogr 19:264–267
Spoto GP, Press GA, Hesselink JR, Solomon M (1990) Intracranial ependymoma and subependymoma: MR manifestations. Am J Neuroradiol 11:83–91
Stevens JM, Kendall BE, Love S (1984) Radiological features of subependymoma with emphasis on computed tomography. Neuroradiology 26:223–228
Sugo N, Kuroki T, Nemoto M, Mito T, Seiki Y, Shibata I (2000) Difference in 201TlCl accumulation mechanism in brain tumors: a comparison of their Na(+)-K+ ATPase activities. Kaku Igaku 37:311–318
Swatz JD, Zimmerman RA, Bilaniuk LT (1982) Computed tomography of intracranial ependymoma. Radiology 143:97–101
Tamura M, Shibasaki T, Zama A, Kurihara H, Horikoshi S, Ono N, Oriuchi N, Hirano T (1998) Assessment of malignancy of glioma by positron emission tomography with 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride. Neuroradiology 40:210–215
Tugnoli V, Tosi MR, Barbarella G, Ricci R, Calbucci F, Bertoluzza A (1997) In vitro and in vivo MR study of human glioma metabolites. Int J Oncol 11:319–324
Tugnoli V, Tosi MR, Barbarella G, Ricci R, Leonardi M, Calbucci F, Bertoluzza A (1998) Magnetic resonance spectroscopy study of low grade extra and intracerebral human neoplasms. Oncol Rep 5:1199–1203
Ueda T, Kaji Y, Wakisaka S, Hoshi H, Jinnouchi S, Futami S (1993) Time sequential single photon emission computed tomography studies in brain tumour using thallium-201. Eur J Nucl Med 20:138–145
Vaquero J, Cabezudo JM, Nombela L (1983) CT scan in subependymomas. Br J Radiol 56:425–426
Vuori K, Kankaanranta L, Hakkinen AM, Gaily E, Valanne L, Granstrom ML, Joensuu H, Blomstedt G, Paetau A, Lundbom N (2004) Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology 230:703–708
Yamasaki T, Kikuchi H, Higashi T, Yamabe H, Moritake K (1990) Two surgically cured cases of subependymoma with emphasis on magnetic resonance imaging. Surg Neurol 33:329–335
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kawaguchi, T., Kumabe, T., Shimizu, H. et al. 201Tl-SPECT and 1H-MRS study of benign lateral ventricle tumors: differential diagnosis of subependymoma. Neurosurg Rev 28, 96–103 (2005). https://doi.org/10.1007/s10143-004-0353-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-004-0353-6